Abstract
This first report of a Swiss registry includes 313 patients with primary immunodeficiency syndromes (PIDS) who were observed between January 1975 and January 1985. Diagnosis of specific PIDS was made according to WHO criteria. The most frequent disorders were IgA deficiency (33%) and common variable immunodeficiency (22%), followed by selective deficiency of other immunoglobulin isotypes (9%), severe combined immunodeficiency (9%), infantile sex-linked agammaglobulinemia (7%), and Wiskott-Aldrich syndrome (6%). Frequencies of other types of PIDS varied between 0.3 and 4%. Half of the patients were in the pediatric age group. Male patients predominated (63%). In addition to respiratory and urogenital tract infections, autoimmune disorders were observed in 14 patients with IgA deficiency or common variable immunodeficiency. IgA deficiency was, furthermore, associated with atopic and neurological disorders. A comparison with other national registries revealed some differences: the frequency of severe combined immunodeficiency was high (incidence, 24.3 cases per 106 live births), and that of ataxia teleangiectasia was particularly low (1.4 per 106 live births) in Switzerland. Frequencies of the three major PIDS groups of (i) predominantly antibody defects, (ii) predominantly cell-mediated defects, and (iii) PIDS associated with other major defects agreed with those reported in the other European studies.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Rosen FS, Cooper MD, Wedgwood RJP: The primary immunodeficiencies. N Engl J Med 311:235–242, 300–310, 1984
Conley ME, Brown P, Pickard AR, Buckley RH, Miller DS, Raskind WH, Singer JW, Fialkow PJ: Expression of the gene defect in X-linked agammaglobulinemia. N Engl J Med 315:564–567, 1986
Hayakawa H, Jwata T, Kobayashi N: Primary Immunodeficiency syndrome in Japan. I. Overview of a national-wide survey on primary immunodeficiency. J Clin Immunol 1:31–39, 1981
Hayakawa H, Matsumoto S, Kabayashi N, Yata J: Genetically determined immunodeficiencies.In The Nature, Cellular, and Biochemical Basis and Management of Immunodeficiencies, Symposia Medica Hoechst 21, RA Good, E Lindenlaub (eds). Stuttgart, New York, Schattauer Verlag, 1987, pp 39–60
Fasth A: Primary immunodeficiency disorders in Sweden: Cases among children 1974–1979. J Clin Immunol 2:86–92, 1982
Fasth A: Immunodeficiency in children in Sweden 1974–1983. From the Swedish register of primary immunodeficiency disorders.In Progress in Immunodeficiency Research and Therapy, Vol I, C Griscelli, J Vossen (eds), Amsterdam, New York, Elsevier, 1984, pp 461–467
Luzi G, Businco L, Aiuti F: Primary immunodeficiency syndromes in Italy: A report of the National Register in children and adults. J Clin Immunol 3:316–321, 1983
World Health Organization: Report of a scientific group on immunodeficiency. Clin Immunol Immunopathol 28:450–475, 1983
Bundesamt für Statistik: Statistisches Jahrbuch der Schweiz. Basel, Birkhäuser Verlag, 1984
Morell A, Muehlheim E, Schaad U, Skvaril F, Rossi E: Susceptibility to infections in children with selective IgA-and IgA-IgG subclass deficiency. Eur J Pediatr 145:199–203, 1986
Fontana A, Grob PJ: Immunoglobulin deficiency, HLA antigens and seizures. Ann Intern Med 88:429, 1978
Clark, JA, Callicoat PA, Brenner NA, Bradley CA, Smith DM: Selective IgA deficiency in blood donors. Am J Clin Pathol 80:210–213, 1983
Kanoh T, Mizumoto T, Yasuda N, Koya M, Ohno Y, Uchino H, Yoshimura K, Ohkubo Y, Yamaguchi H: Selective IgA deficiency in Japanese blood donors: Frequency and statistical analysis. Vox Sang 50:81–86, 1986
Kinlen LJ, Webster ADB, Bird AG, Haile R, Soothill JF, Thompson RA: Prospective study of cancer in patients with hypogammaglobulinemia. Lancet 1:263–266, 1985
Filipovich AH, Spector BD, Kersey J: Immunodeficiency in humans as a risk factor in the development of malignancy. Prev Med 9:252–259, 1980
Spector BD, Perry GS III, Kersey JH: Genetically determined immunodeficiency disease (GDID) and malignancy: Report from the immunodeficiency-cancer registry. Clin Immunol Immunopathol 11:12–29, 1978
Cunningham-Rundles C, Siegal FP, Smithwick EM, Lion-Boulé A, Cunningham-Rundles S, O'Malley J, Barandun S, Good RA: Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease. Ann Intern Med 101:435–439, 1984
O'Reilly RJ, Brochstein J, Dinsmore R, Kirkpatrick D: Morrow transplantation for congenital disorders. Semin Hematol 21:188–221, 1984
Fischer A, Griscelli C, Friedrich W, Kubanek B, Levinsky R, Morgan G, Vossen J, Wagemaker G, Landais P: Bone marrow transplantation for immunodeficiencies and osteopetrosis: European survey, 1968–1985. Lancet 2:1080–1084, 1986
Beatty PG, Clift RA, Michelson EM, Nisperos BB, Flournoy N, Martin PJ, Sanders JE, Stewart P, Buckner CD, Storb R, Thomas ED, Hansen JA: Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 313:765–771, 1985
Friedrich W, Goldmann SF, Kleihauer E: Treatment of primary immunodeficiencies by bone marrow transplantation.In The Nature, Cellular, and Biochemical Basis and Management of Immunodeficiencies, Symposia Medica Hoechst 21, RA Good, E Lindenlaub (eds). Stuttgart, New York, Schattauer Verlag, 1987, pp 95–105
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ryser, O., Morell, A. & Hitzig, W.H. Primary immunodeficiencies in Switzerland: First report of the national registry in adults and children. J Clin Immunol 8, 479–485 (1988). https://doi.org/10.1007/BF00916954
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00916954